Asia

GSK, A*STAR's ICES to develop new medicines for emerging markets

Wednesday, April 10, 2013 09:17 AM

GlaxoSmithKline and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a five-year strategic agreement to develop new evidence based formulations (EBFs) specifically for emerging markets. EBFs are medicines which are reformulated to provide additional patient benefit.

More... »


TheraVida, SK Chemicals to develop THVD-201 and THVD-202 for OAB, UUI

Wednesday, April 3, 2013 11:45 AM

TheraVida, a biopharmaceutical company based in Mountain View, Calif., and South Korea-based SK Chemicals have signed a license agreement for two of TheraVida's proprietary combination drug product candidates, THVD-201 and THVD-202. The agreement grants SK Chemicals exclusive rights to develop and commercialize THVD-201 and THVD-202 in South Korea for the treatment of overactive bladder (OAB) and urge urinary incontinence (UUI). 

More... »


AG Mednet, Biovisiq team up to bring clinical trial solutions to Asian market

Wednesday, April 3, 2013 09:49 AM

Executing its mission to bring zero-delay imaging technology to clinical trials around the world, AG Mednet has signed a Master Services Agreement with Biovisiq, a Japanese imaging core laboratory (ICL), with an aim to set the new industry standard for imaging data quality, compliance and efficiency.

More... »

Edison, Dainippon Sumitomo to develop orphan mitochondrial and adult CNS disease drugs

Friday, March 29, 2013 01:09 PM

Specialty pharmaceutical company Edison Pharmaceuticals has entered into a R&D and commercialization agreement with Dainippon Sumitomo Pharma, a Japanese pharmaceutical company, for the development of EPI-743 and EPI-589 in Japan.

More... »

ShangPharma’s shareholders approve merger agreement

Monday, March 25, 2013 10:02 AM

China-based pharmaceutical and biotechnology R&D outsourcing company ShangPharma’s shareholders have voted in favor of merger agreement in which ShangPharma Merger Sub will merge with ShangPharma, with the new entity being a wholly owned subsidiary of ShangPharma Parent.

More... »

Domain, Elite Consulting to create, invest in life science companies in China

Thursday, March 14, 2013 08:00 AM

Domain Associates, a U.S. venture capital firm investing in breakthrough life sciences technologies, and Elite Consulting, consultants and financial advisors to the Chinese pharmaceutical and medical device industry, have formed a partnership to bring the most advanced healthcare products and technologies to China. 

More... »

Marken opens pharmaceutical depot in Beijing

Monday, March 11, 2013 11:07 AM

Marken, a global clinical supply chain solutions provider, has completed its new pharmaceutical depot in Beijing, China. The new facility which provides 850 square meters of GMP compliant space for temperature controlled storage as well as distribution of clinical trial supplies is co-located with the existing Marken Beijing branch office to provide a fully integrated and best in class service to clients.

More... »

Catalent announces major China expansion with two new facilities

Monday, March 11, 2013 10:09 AM

Catalent Pharma Solutions, a global drug development solutions provider, announced two joint ventures in China for its Softgel Technologies and Clinical Supply Solutions businesses. 

More... »

GVK Biosciences selects GGA as new distributor in Taiwan

Monday, February 25, 2013 11:55 AM

GVK Biosciences, a provider of databases and services to the life sciences industry, has selected Genesis Genetics Asia (GGA) as its distributor for its Informatics Database products and services in Taiwan.

More... »

Amgen to build state-of-the-art manufacturing facility in Singapore

Friday, January 18, 2013 02:49 PM

Amgen, a biotech based in Thousand Oaks, Calif., plans to build a new manufacturing facility in the Tuas Biomedical Park area of Singapore.

More... »

`

CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs